J&J to Buy Cardiovascular Technology Abiomed in $16.6B Deal
Johnson & Johnson is spending about $16.6 billion to buy cardiovascular technology company Abiomed and build up its medical device division.
Johnson & Johnson is spending about $16.6 billion to buy cardiovascular technology company Abiomed and build up its medical device division.
BP’s earnings have more than doubled in the third quarter as the London-based energy giant benefited from high oil and natural gas prices following Russia’s invasion of Ukraine.
Toyota Motor Corp. says its profit fell 31% in the last quarter as a shortage of computer chips offset foreign exchange gains from a weaker yen.
Oil giant Saudi Aramco is reporting a $42.4 billion profit in the third quarter of this year, buoyed by higher global energy prices that have filled the kingdom’s coffers but helped fuel inflation worldwide.
Billionaire Elon Musk is already floating major changes for Twitter as he begins his first week as owner of the social-media platform.
There will also be several key reports on the health of the labor market.
President Joe Biden is raising the possibility of imposing a windfall tax on oil companies if they don’t boost domestic production.
Stocks ended lower on Wall Street, but major indexes still wound up with big gains for October, including the best month for the Dow Jones Industrial Average since 1976.
Dominion Energy has agreed to implement several consumer protections in connection with its massive offshore wind project under a proposed agreement with the office of the Virginia attorney general and other parties.
Wall Street closed sharply higher, capping another strong week with gains led by Apple and other companies that made even bigger profits during the summer than expected.